sellWeak
Yuval Wasserman sold $221k of FARO
director at FARO TECHNOLOGIES INC. 11,972 shares at an average of $18.45, traded Nov 5, 2024, filed Nov 7, 2024.
Warning score
27Value
$221k
11,972 shares
Holdings after
159,170
-7% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleDirector
- +12Trade size$221k at market
- 0Share of holdings soldSold 7.0% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001628280-24-046348, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 5, 2024 | SOpen-market sale Common Stock | -6,222 | $17.75 | $110k | 164,920 | Nov 7, 2024 |
| Nov 6, 2024 | SOpen-market sale Common Stock | -5,750 | $19.21 | $110k | 159,170 | Nov 7, 2024 |
Related signals
Other insiders at FARO TECHNOLOGIES INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 30Weak | FARO TECHNOLOGIES INC | Matthew Horwath SVP & Chief Financial Officer | $4,714 166 shares | -0% | |
| 44Moderate | FARO TECHNOLOGIES INC | Peter James Lau President and CEO | $135k 4,617 shares | -3% | |
| 36Weak | FARO TECHNOLOGIES INC | Matthew Horwath SVP & Chief Financial Officer | $43k 1,480 shares | -4% | |
| 30Weak | FARO TECHNOLOGIES INC | Matthew Horwath SVP & Chief Financial Officer | $13k 439 shares | -1% | |
| 27Weak | FAROsell FARO TECHNOLOGIES INC | Yuval Wasserman director | $177k 5,658 shares | -4% | |
| 22Weak | FAROsell FARO TECHNOLOGIES INC | Matthew Horwath SVP & Chief Financial Officer | $17k 645 shares | -2% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.